Hugel's "Botulax" Consensus Study Published in SCI International Journal

Hugel announced on the 21st that research on its botulinum toxin (BTX) product 'Botulax' has been published in the SCI-level international aesthetic and plastic surgery journal, 'Aesthetic Surgery Journal.'

Hugel logo. [Image provided by Hugel]

The literature is a consensus study (Expert Consensus Report) involving a total of 10 experts from Hugel's China aesthetic and plastic surgery KOL academic network 'C-GEM (China-Global Expert Members)' as well as experts from Thailand and Korea, containing botulinum toxin injection techniques and know-how by area for Asians.

A consensus study is a document in which medical professionals write opinions and recommendations on specific procedures and drugs based on field experience. Hugel explained that this data is meaningful in that it can be used as a guideline in actual clinical practice.

The research team presented Asia-specific injection strategies in three aspects using Hugel's Botulax: removal of wrinkles on the glabella, around the eyes, nose, and mouth; contouring procedures for the square jaw, parotid gland, and temple areas; and lifting of the eyebrows, mouth corners, and jawline.

Hugel explained that the announcement of this consensus study reflects the latest trends tailored to the needs of Asian patients and will serve as new medical evidence for full-face rejuvenation procedures.

Botulax (export product name Retivo) has maintained the number one market share in Korea for seven consecutive years. It also achieved the top position in Thailand with about a 50% market share. Additionally, as the first domestic company to enter the Chinese market, Hugel is actively conducting genuine product certification activities in line with local policies and carrying out vigorous sales and marketing activities.

A Hugel official stated, "We plan to continuously expand customized academic content and networks by region, including Asia. We will make company-wide efforts to promote the differentiated value of Botulax and the company through evidence-based marketing and to expand the global market."

This content was produced with the assistance of AI translation services.